Synthesis and Opioid Receptor Binding Affinities of 2-Substituted and 3-Aminomorphinans: Ligands for μ, κ, and δ Opioid Receptors

The phenolic group of the potent μ and κ opioid morphinan agonist/antagonists cyclorphan and butorphan was replaced by phenylamino and benzylamino groups including compounds with para-substituents in the benzene ring. These compounds are highly potent μ and κ ligands, e.g., p-methoxyphenylaminocyclo...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicinal chemistry Vol. 53; no. 1; pp. 402 - 418
Main Authors Decker, Michael, Si, Yu-Gui, Knapp, Brian I, Bidlack, Jean M, Neumeyer, John L
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 14.01.2010
Amer Chemical Soc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The phenolic group of the potent μ and κ opioid morphinan agonist/antagonists cyclorphan and butorphan was replaced by phenylamino and benzylamino groups including compounds with para-substituents in the benzene ring. These compounds are highly potent μ and κ ligands, e.g., p-methoxyphenylaminocyclorphan showing a K i of 0.026 nM at the μ receptor and a K i of 0.03 nM at the κ receptor. Phenyl carbamates and phenylureas were synthesized and investigated. Selective o-formylation of butorphan and levorphanol was achieved. This reaction opened the way to a large set of 2-substituted 3-hydroxymorphinans, including 2-hydroxymethyl-, 2-aminomethyl-, and N-substituted 2-aminomethyl-3-hydroxymorphinans. Bivalent ligands bridged in the 2-position were also synthesized and connected with secondary and tertiary aminomethyl groups, amide bonds, and hydroxymethylene groups, respectively. Although most of the 2-substituted morphinans showed considerably lower affinities compared to their parent compounds, the bivalent ligand approach led to significantly higher affinities compared to the univalent 2-substituted morphinans.
Bibliography:Medline
NIH RePORTER
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-2623
1520-4804
DOI:10.1021/jm9013482